- Event to Be Webcast June 12 at 5:15 p.m. Eastern Time - - PAS-Port(R) System Clinical Data To Be Presented During Late Breaking News Session of International Society for Minimally Invasive Cardiothoracic
Surgery Annual Meeting -
REDWOOD CITY, Calif., June 9 /PRNewswire-FirstCall/ -- Cardica, Inc. (Nasdaq: CRDC) today announced that it will webcast an investor briefing on the topic of "Revolutionizing Revascularization" on Thursday, June 12, at 5:15 p.m. Eastern Time in Boston. The event will feature a panel of renowned cardiovascular surgeons who will discuss how surgeons are integrating new techniques to improve coronary artery bypass graft (CABG) procedures, including the use of Cardica's C-Port(R) Distal Anastomosis Systems, which are designed to allow surgeons to automate the attachment of blood vessel grafts during CABG procedures, replacing traditional hand-sewn sutures.
The Company also announced that data from the 220-patient prospective,
randomized pivotal clinical trial of its PAS-Port(R) Proximal Anastomosis
System will be presented at the 2008 Annual Scientific Meeting of the
International Society for Minimally Invasive Cardiothoracic Surgery
(ISMICS) in Boston. The presentation, entitled "The Cardica PAS-Port
Proximal Anastomotic Connector Device: First Report of the Results of the
FDA Trial," will be given during the Late Breaking News session on
Thursday, June 12, at 1:15 p.m. Eastern Time by principal study
investigator John D. Puskas, M.D., chief of cardiac surgery at Emory
Crawford Long Hospital in Atlanta. As previously announced, the trial,
which compared graft vessel connections made using the PAS-Port system to
conventional hand-sewn sutures during CABG procedures, achieved all of its
primary and secondary endpoints. Based on the positive trial data, Cardica
submitted a 510(k) premarket notification in April to the U.S. Food and
Drug Administration for the PAS-Port system.
Panelists for the investor event will include:
-- Husam H. Balkhy, M.D., chairman of cardiothoracic surgery at The
Wisconsin Heart Hospital and clinical assistant professor of surgery at
the Medical College of Wisconsin. He is a well-known advocate of
minimally-invasive cardiac surgery and has the largest experience in
the United States with distal anastomotic devices in coronary artery
-- Robert S. Poston, M.D., chief of cardiac surgery at Boston Medical
Center. Previously, he was an associate professor of surgery at the
University of Maryland where he focused his activities in the field of
off-pump and minimally-invasive/robotic CABG. His research into
minimally-invasive CABG and the hybrid procedure was recognized in 2005
by the Daily Record magazine as an "Innovation of the Year."
-- Sudhir Srivastava, M.D., director of robotic and minimally-invasive
cardiac surgery at the University of Chicago Medical Center. He
pioneered both the da Vinci revascularization and port-only coronary
artery bypass surgical methods and has performed more of these
procedures than any other surgeon in the world.
The event will be webcast live on Thursday, June 12, at 5:15 p.m. Eastern Time. To access the live and subsequently archived webcast of the discussion, go to the Investor Relations section of Cardica's website at http://www.cardica.com. Please connect to the website at least 15 minutes prior to the webcast to allow for any necessary software downloads.
Cardica is a leading provider of automated anastomosis systems for coronary artery bypass graft (CABG) surgery. By replacing hand-sewn sutures with easy-to-use automated systems, Cardica's products provide cardiovascular surgeons with rapid, reliable and consistently reproducible anastomoses, or connections of blood vessels, often considered the most critical aspect of the CABG procedure. Cardica's C-Port(R) Distal Anastomosis Systems are marketed in Europe and the United States. The PAS-Port(R) Proximal Anastomosis System is marketed in Europe and Japan, and Cardica has submitted a 510(k) premarket notification for clearance to market the PAS-Port system in the United States. Cardica also is developing additional devices with Cook Medical to facilitate vascular closure and other surgical procedures.
|SOURCE Cardica, Inc.|
Copyright©2008 PR Newswire.
All rights reserved